Lindbrook Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $102 | Buy |
+13
| New | +$102 | ﹤0.01% | 2751 |
|
|
2024
Q3 | – | Sell |
-128
| Closed | -$1.95K | – | 2896 |
|
|
2024
Q2 | $1.95K | Buy |
128
+76
| +146% | +$1.16K | ﹤0.01% | 2346 |
|
|
2024
Q1 | $982 | Hold |
52
| – | – | ﹤0.01% | 2425 |
|
|
2023
Q4 | $993 | Buy |
+52
| New | +$993 | ﹤0.01% | 2465 |
|
|
2022
Q3 | – | Sell |
-59
| Closed | -$1K | – | 2881 |
|
|
2022
Q2 | $1K | Buy |
59
+9
| +18% | +$153 | ﹤0.01% | 2343 |
|
|
2022
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 2061 |
|
|
2021
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 1814 |
|
|
2021
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 1592 |
|
|
2021
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 1807 |
|
|
2021
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 1770 |
|
|
2020
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 1670 |
|
|
2020
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 1623 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 1611 |
|
|
2020
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 1428 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 1516 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 1484 |
|
|
2019
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 1491 |
|
|
2018
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 1427 |
|